Halon David A, Ayman Jubran, Rubinshtein Ronen, Zafrir Barak, Azencot Mali, Lewis Basil S
Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, Haifa, Israel.
Cardiology. 2017;138(4):218-227. doi: 10.1159/000478995. Epub 2017 Aug 18.
Predictive models for heart failure (HF) in heterogeneous populations have had limited success. We examined cardiac computed tomography angiography (CTA) predictors of HF or cardiovascular death (HF-CVD) in a prospective study of asymptomatic diabetics undergoing baseline assessment by CTA.
The subjects (n = 735, aged 55-74 years, 51.2% women) had no clinical history of cardiovascular disease at study entry. Coronary artery calcium (CAC) score, CTA-defined coronary atherosclerosis, cardiac chamber volumes, and clinical data were collected and late outcome events recorded over 8.4 ± 0.6 years (range 7.3-9.3).
HF-CVD occurred in 41 (5.6%) subjects, with HF occurring mostly (19/23, 82.6%) in subjects without preceding myocardial infarction. Baseline univariate clinical outcome predictors of HF-CVD included older age (p = 0.027), the duration of diabetes (p = 0.004), HbA1c (p < 0.0001), microvascular disease (retinopathy, microalbuminuria) (p < 0.0001), and systolic blood pressure (p = 0.035). Baseline univariate CTA predictors included CAC score (p = 0.004), coronary stenosis (p = 0.047), and a CTA-defined left/right atrial (LA/RA) volume ratio >1 (p < 0.0001). Independent predictors were an LA/RA volume ratio >1, microvascular disease, and systolic blood pressure (model C-statistic 0.792, 95% CI 0.758-0.824). Measures of the extent of coronary artery disease (CAD) were not independent predictors of HF-CVD.
In a low- to moderate-risk asymptomatic diabetic population, CTA LA enlargement (LA/RA volume ratio) but not the extent of CAD had independent prognostic value for HF-CVD in addition to the clinical variables.
针对异质性人群的心力衰竭(HF)预测模型成效有限。我们在一项对无症状糖尿病患者进行心脏CT血管造影(CTA)基线评估的前瞻性研究中,研究了HF或心血管死亡(HF-CVD)的心脏CTA预测因素。
研究纳入的受试者(n = 735,年龄55 - 74岁,女性占51.2%)在研究开始时无心血管疾病临床病史。收集冠状动脉钙化(CAC)评分、CTA定义的冠状动脉粥样硬化、心腔容积及临床数据,并记录8.4±0.6年(范围7.3 - 9.3年)内的晚期结局事件。
41名(5.6%)受试者发生HF-CVD,其中HF大多发生在无既往心肌梗死的受试者中(19/23,82.6%)。HF-CVD的基线单因素临床结局预测因素包括年龄较大(p = 0.027)、糖尿病病程(p = 0.004)、糖化血红蛋白(HbA1c)(p < 0.0001)、微血管疾病(视网膜病变、微量白蛋白尿)(p < 0.0001)和收缩压(p = 0.035)。基线单因素CTA预测因素包括CAC评分(p = 0.004)、冠状动脉狭窄(p = 0.047)以及CTA定义的左/右心房(LA/RA)容积比>1(p < 0.0001)。独立预测因素为LA/RA容积比>1、微血管疾病和收缩压(模型C统计量0.792,95%CI 0.758 - 0.824)。冠状动脉疾病(CAD)程度的指标并非HF-CVD的独立预测因素。
在低至中度风险的无症状糖尿病患者群体中,除临床变量外,CTA显示的左心房扩大(LA/RA容积比)而非CAD程度对HF-CVD具有独立的预后价值。